A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis.
about
Pharmacotherapy for uveitis: current management and emerging therapy.Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trialRapamycin ameliorates experimental autoimmune uveoretinitis by inhibiting Th1/Th2/Th17 cells and upregulating CD4+CD25+ Foxp3 regulatory T cells.In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device.Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE StudyTreatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.Systemic treatment of vitreous inflammation.Systemic treatments for noninfectious vitreous inflammation.Emerging therapies for noninfectious uveitis: what may be coming to the clinicsCurrent advances in the treatment of neovascular age-related macular degeneration.Rapamycin-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles: preparation, characterization and potential application in corneal transplantation.The Effect of Different Dosing Schedules of Intravitreal Sirolimus, a Mammalian Target of Rapamycin (mTOR) Inhibitor, in the Treatment of Non-Infectious Uveitis (An American Ophthalmological Society Thesis).Therapeutic drug repositioning using personalized proteomics of liquid biopsies.
P2860
Q34274075-B449D2AD-2F82-492C-9C33-DD1426CDA1F5Q35085846-150364A9-B3BC-461E-8591-E2F5649BDCC4Q35964539-93D91C19-4CC5-4A8B-8DF9-BE519E4157B4Q36273801-7818FB1C-B617-48BF-BC31-62FAE7B74432Q36722548-57F28717-3146-464F-AC52-0B85EFD06944Q36801990-D3B5C310-BF76-48AF-84E9-BEF8B6BFEABEQ38048774-BD19A119-468A-4751-B7A7-E0959D52A7B1Q38172090-5CFEC459-60C2-4991-B067-7D78354C05D4Q38215514-CDB411CC-9697-492D-B175-ADE6AA2CC260Q38902191-25D60A07-581F-4EDF-8ED9-4CE45D615AA6Q39014772-F0D686EC-7752-453C-9ACF-D322FBD43C39Q40539739-795CC2BD-BEA3-452E-9C7D-0FFD748CE05BQ47268970-ADB2FF72-43D9-4FC3-B1AD-8DFEB9B1F9E8
P2860
A retrospective review of oral low-dose sirolimus (rapamycin) for the treatment of active uveitis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A retrospective review of oral ...... e treatment of active uveitis.
@ast
A retrospective review of oral ...... e treatment of active uveitis.
@en
A retrospective review of oral low-dose sirolimus
@nl
type
label
A retrospective review of oral ...... e treatment of active uveitis.
@ast
A retrospective review of oral ...... e treatment of active uveitis.
@en
A retrospective review of oral low-dose sirolimus
@nl
prefLabel
A retrospective review of oral ...... e treatment of active uveitis.
@ast
A retrospective review of oral ...... e treatment of active uveitis.
@en
A retrospective review of oral low-dose sirolimus
@nl
P2860
P1476
A retrospective review of oral ...... e treatment of active uveitis.
@en
P2093
Brandon N Phillips
Keith J Wroblewski
P2860
P2888
P356
10.1007/S12348-010-0015-5
P577
2010-12-07T00:00:00Z
P5875
P6179
1002600081